Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer

Biochemical and Biophysical Research Communications

Volumn 341, Issue 1, 2006, Pages 73-81

  Planas Silva, Maricarmen D ^a   Bruggeman, Richard D ^a   Grenko, Ronald T ^a   Stanley Smith, J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; c Src tyrosine kinase; Estrogen; Estrogen receptor; Focal adhesion kinase; Metastasis; Tamoxifen resistance; Tumor biomarker

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; FOCAL ADHESION KINASE; PROTEIN TYROSINE KINASE; TAMOXIFEN;

ARTICLE; AUTOPHOSPHORYLATION; BREAST CANCER; CELL PROLIFERATION; HUMAN; HUMAN CELL; METASTASIS; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; ENZYME ACTIVATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 31044447246     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.164     Document Type: Article

References (53)

1. A. Howell Future use of selective estrogen receptor modulators and aromatase inhibitors Clin. Cancer Res. 7 2001 4402s 4410s
2. R. Clarke, F. Leonessa, J.N. Welch, and T.C. Skaar Cellular and molecular pharmacology of antiestrogen action and resistance Pharmacol. Rev. 53 2001 25 71
3. S. Ali, and R.C. Coombes Endocrine-responsive breast cancer and strategies for combating resistance Nat. Rev. Cancer 2 2002 101 112
4. S.R.D. Johnston, and M. Dowsett Aromatase inhibitors for breast cancer: lessons from the laboratory Nat. Rev. Cancer 3 2003 821 831
5. M. De Laurentiis, G. Arpino, E. Massarelli, A. Ruggiero, C. Carlomagno, F. Ciardiello, G. Tortora, D. D'Agostino, F. Caputo, G. Cancello, E. Montagna, L. Malorni, L. Zinno, R. Lauria, A.R. Bianco, and S. De Placido A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer Clin. Cancer Res. 11 2005 4741 4748
6. E.R. Levin Integration of the extra-nuclear and nuclear actions of estrogen Mol. Endocrinol. 19 2005 1951 1959
7. G. Castoria, A. Migliaccio, A. Bilancio, M. Di Domenico, A. de Falco, M. Lombardi, R. Fiorentino, L. Varricchio, M.V. Barone, and F. Auricchio PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells EMBO J. 20 2001 6050 6059
8. R. Ishizawar, and S.J. Parsons c-Src and cooperating partners in human cancer Cancer Cell 6 2004 209 214
9. M.A. Shupnik Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation Oncogene 23 2004 7979 7989
10. W. Feng, P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P.J. Kushner Pontentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway Mol. Endocrinol. 15 2001 32 45
11. Y.M. Shah, and B.G. Rowan The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor α promoter interaction and elevated steroid receptor coactivator 1 activity Mol. Endocrinol. 19 2005 732 748
12. J.S. Biscardi, R.C. Ishizawar, C.M. Silva, and S.J. Parsons Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer Breast Cancer Res. 2 2000 203 210
13. J.M. Summy, and G.E. Gallick Src family kinases in tumor progression and metastasis Cancer Metastasis Rev. 22 2003 337 358
14. T.J. Yeatman A renaissance for SRC Nat. Rev. Cancer 4 2004 470 480
15. G.W. McLean, N.O. Carragher, E. Avizienyte, J. Evans, V.G. Brunton, and M.C. Frame The role of focal-adhesion kinase in cancer-a new therapeutic opportunity Nat. Rev. Cancer 5 2005 505 515
16. S.K. Mitra, D.A. Hanson, and D.D. Schlaepfer Focal adhesion kinase: in command and control of cell motility Nat. Rev. Mol. Cell. Biol. 6 2005 56 68
17. J.T. Parsons Focal adhesion kinase: the first ten years J. Cell Sci. 116 2003 1409 1416
18. V. Gabarra-Niecko, M.D. Schaller, and J.M. Dunty FAK regulates biological processes important for the pathogenesis of cancer Cancer Metastasis Rev. 22 2003 359 374
19. A.L. Lark, C.A. Livasy, L. Dressler, D.T. Moore, R.C. Millikan, J. Geradts, M. Iacocca, D. Cowan, D. Little, R.J. Craven, and W. Cance High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype Mod. Pathol. 18 2005 1289 1294
20. FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome Breast Cancer Res. 7 2005 R194 R203
21. F. Wang, R.K. Hansen, D. Radisky, T. Yoneda, M.H. Barcellos-Hoff, O.W. Petersen, E.A. Turley, and M.J. Bissell Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts J. Natl. Cancer Inst. 94 2002 1494 1503
22. V. Novaro, C.D. Roskelley, and M.J. Bissell Collagen-IV and laminin-1 regulate estrogen receptor α expression and function in mouse mammary epithelial cells J. Cell Sci. 116 2003 2975 2986
23. T.L. Woodward, H. Lu, and S.Z. Haslam Laminin inhibits estrogen action in human breast cancer cells Endocrinology 141 2000 2814 2821
24. D. Sisci, S. Aquila, E. Middea, M. Gentile, M. Maggiolini, F. Mastroianni, D. Montanaro, and S. Ando Fibronectin and type IV collagen activate ERα AF-1 by c-Src pathway: effect on breast cancer cell motility Oncogene 23 2004 8920 8930
25. R.L. Kilker, M.W. Hartl, T.M. Rutherford, and M.D. Planas-Silva Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells J. Steroid Biochem. Mol. Biol. 92 2004 63 71
26. M.D. Planas-Silva, and R.A. Weinberg Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution Mol. Cell. Biol. 17 1997 4059 4069
27. K.A. Matkowskyj, K. Keller, S. Glover, L. Kornberg, R. Tran-Son-Tay, and R.V. Benya Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407 J. Histochem. Cytochem. 51 8 2003 1041 1048
28. C.-W. Wong, C. McNally, E. Nickbarg, B.S. Komm, and B.J. Cheskis Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade Proc. Natl. Acad. Sci. USA 99 2002 14783 14788
29. A. Migliaccio, M. Pagano, and F. Auricchio Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells Oncogene 8 1993 2183 2191
30. D.D. Schlaepfer, S.K. Mitra, and D. Ilic Control of motile and invasive cell phenotypes by focal adhesion kinase Biochim. Biophys. Acta 1692 2004 77 102
31. P.J. Bartholomew, J.M. Vinci, and J.A. DePasquale Decreased tyrosine phosphorylation of focal adhesion kinase after estradiol treatment of MCF-7 human breast carcinoma cells J. Steroid Biochem. Mol. Biol. 67 1998 241 249
32. V.G. Brunton, E. Avizienyte, V.J. Fincham, B. Serrels, C.A. Metcalf III, T.K. Sawyer, and M.C. Frame Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior Cancer Res. 65 2005 1335 1342
33. S. Hiscox, L. Morgan, D. Barrow, C. Dutkowskil, A. Wakeling, and R.I. Nicholson Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib ('Iressa', ZD1839) Clin. Exp. Metastasis 21 2004 201 212
34. R.X.-D. Song, R.A. McPherson, L. Adam, Y. Bao, M. Shupnik, R. Kumar, and R.J. Santen Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation Mol. Endocrinol. 16 2002 116 127
35. M. Tujague, J.S. Thomsen, K. Mizuki, C.M. Sadek, and J.-Å. Gustafsson The focal adhesion protein vinexin α regulates the phosphorylation and activity of estrogen receptor α J. Biol. Chem. 279 2004 9255 9263
36. D.M. Lonard, Z. Nawaz, C.L. Smith, and B.W. O'Malley The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation Mol. Cell 5 2000 939 948
37. D. Rai, A. Frolova, J. Frasor, A.E. Carpenter, and B.S. Katzenellenbogen Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells Mol. Endocrinol. 19 2005 1606 1617
38. H. Rochefort, N. Platet, Y. Hayashido, D. Derocq, A. Lucas, S. Cunat, and M. Garcia Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview J. Steroid Biochem. Mol. Biol. 65 1998 163 168
39. S. Saji, M. Kawakami, S. Hayashi, N. Yoshida, M. Hirose, S. Horiguchi, A. Itoh, N. Funata, S.L. Schreiber, M. Yoshida, and M. Toi Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer Oncogene 24 2005 4531 4539
40. J.H. Hanke, J.P. Gardner, R.L. Dow, P.S. Changelian, W.H. Brisette, E.J. Weringer, B.A. Pollok, and P.A. Connelly Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor J. Biol. Chem. 271 1996 695 701
41. ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor EMBO J. 17 1998 2008 2018
42. M.J. van Nimwegen, S. Verkoeijen, L. van Buren, D. Burg, and B. van de Water Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation Cancer Res. 65 2005 4698 4706
43. A. Stewart, C. Ham, and I. Zachary The focal adhesion kinase amino-terminal domain localises to nuclei and intercellular junctions in HEK 293 and MDCK cells independently of tyrosine 397 and the carboxy-terminal domain Biochem. Biophys. Res. Commun. 299 2002 62 73
44. E.W. Thompson, N. Brunner, J. Torri, M.D. Johnson, V. Boulay, A. Wright, M.E. Lippman, P.S. Steeg, and R. Clarke The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells Clin. Exp. Metastasis 11 1993 15 26
45. S. van der Flier, A. Brinkman, M.P. Look, E.M. Kok, M.E. Meijer-van Gelder, J.G.M. Klijn, L.C.J. Dorssers, and J.A. Foekens Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment J. Natl. Cancer Inst. 92 2000 120 127
46. C.K. Osborne, V. Bardou, T.A. Hopp, G.C. Chamness, S.G. Hilsenbeck, S.A.W. Fuqua, J. Wong, D.C. Allred, G.M. Clark, and R. Schiff Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer J. Natl. Cancer Inst. 95 2003 353 361
47. S. van der Flier, C.M.W. Chan, A. Brinkman, M. Smid, S.R.D. Johnston, L.C.J. Dorssers, and M. Dowsett BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas Int. J. Cancer 89 2000 465 468
48. V.C.-L. Lin, E.H. Ng, S.E. Aw, M.G.-K. Tan, E.H.-L. Ng, and B.H. Bay Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA Mol. Endocrinol. 14 2000 348 358
49. A. Myoui, R. Nishimura, P.J. Williams, T. Hiraga, D. Tamura, T. Michigami, G.R. Mundy, and T. Yoneda C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis Cancer Res. 63 2003 5028 5033
50. J.M. Knowlden, I.R. Hutcheson, D. Barrow, J.M.W. Gee, and R.I. Nicholson Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor Endocrinology 146 2005
51. Y. Ito, H. Kawakatsu, T. Takeda, N. Tani, N. Kawaguchi, S. Noguchi, T. Sakai, and N. Matsuura Activation of c-Src is inversely correlated with biological aggressiveness of breast carcinoma Breast Cancer Res. Treat. 76 2002 261 267
52. M. Tan, P. Li, K.S. Klos, J. Lu, K.-H. Lan, Y. Nagata, D. Fang, T. Jing, and D. Yu ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis Cancer Res. 65 2005 1858 1867
53. A. Migliaccio, M. Di Domenico, G. Castoria, M. Nanayakkara, M. Lombardi, A. de Falco, A. Bilancio, L. Varricchio, A. Ciociola, and F. Auricchio Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action Cancer Res. 65 2005 10585 10593